Objective: Skin pain in patients with hidradenitis suppurativa (HS) is an important and potentially debilitating symptom impairing patients' health-related quality of life (HRQL). This study quantified HRQL and work productivity benefit associated with lesion control (ie, Hidradenitis Suppurativa Clinical Response, HiSCR – a ≥50% reduction in inflammatory lesion count, and no increase in abscess or draining fistula) and skin pain control (ie, NRS30 – at least 30% reduction on a numerical rating scale between 0 and 10).
http://ift.tt/2sXsUEC
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου